Articles From: MiMedx Announces Receipt Of Civil Subpoena to Minerva Neurosciences shares rally on animal Parkinson's study


MARIETTA, Ga.
Sign-up for MiMedx Announces Receipt Of Civil Subpoena investment picks
COMPANY REPORTS THAT ITS 4TH QUARTER AND FULL YEAR 2014 REVENUES WILL EXCEED UPPER END OF FORECAST MARIETTA, Ga.
Sign-up for MiMedx Comments On Recent FDA Draft Guidance On Minimal Manipulation Of HCT/Ps investment picks
$118.2 MILLION FULL YEAR 2014 REVENUE IS DOUBLE 2013 AND $39.6 MILLION Q4 2014 REVENUE IS 120% INCREASE OVER Q4 2013 MARIETTA, Ga.
Sign-up for MiMedx Exceeds Fourth Quarter And Full Year 2014 Revenue Forecasts investment picks
MARIETTA, Ga.
Sign-up for MiMedx Files Tortious Interference Lawsuit Against Organogenesis investment picks
Company expects 2015 Operating profit margin in excess of 15% MARIETTA, Ga.
Sign-up for MiMedx Raises Expectations For 2015 Revenue To Range From $175 Million To $190 Million investment picks
Shares of MiMedx Group Inc. (MDXG) plunged late Wednesday after the bioimplant company said U.S. regulators are investigating its sales and marketing practices.
Sign-up for MiMedx shares plunge on U.S. sales, marketing probe investment picks
MARIETTA, Ga.
Sign-up for MiMedx To Present At 33rd Annual J.P. Morgan Healthcare Conference investment picks
2014 STIFEL HEALTHCARE CONFERENCE & CANACCORD|GENUITY MEDICAL TECHNOLOGY AND DIAGNOSTICS FORUM MARIETTA, Ga.
Sign-up for MiMedx To Present At Two Healthcare Conferences investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- MiMedx Group Inc. shares are among stocks likely to see activity on Friday as markets reopen after the New Year's holiday.
Sign-up for MiMedx, GM shares in focus Friday investment picks
CHRISTOPHER CASHMAN JOINS MIMEDX AS ITS EXECUTIVE VICE PRESIDENT & CHIEF COMMERCIALIZATION OFFICER MARIETTA, Ga.
Sign-up for MiMedx® Adds New Executive investment picks
DETROIT, Jan.
Sign-up for MindLift Joins Covisint's Certified Partner Program investment picks
2014/12/12
SHENZHEN, China , Dec 12, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 10, 2014 .
Sign-up for Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting investment picks
2015/1/12
SHENZHEN, China , Jan.
Sign-up for Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance investment picks
2014/11/3
SHENZHEN, China , Nov.
Sign-up for Mindray Announces Third Quarter 2014 Financial Results investment picks
2014/11/13
SHENZHEN, China , Nov.
Sign-up for Mindray to Hold Annual General Meeting in Hong Kong on December 10, 2014 investment picks
2015/1/6
SHENZHEN, China , Jan 6, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present in four upcoming investor conferences and events.
Sign-up for Mindray to Participate in Upcoming Investor Conferences and Events investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0988456001&sourceType=1 http://www.ccnmatthews.com/logos/20090331-minera200.jpg LONDON, UNITED KINGDOM and TORONTO, ONTARIO --
Sign-up for Minera IRL Announces Director Resignation investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0985373001&sourceType=1 http://www.ccnmatthews.com/logos/20090331-minera200.jpg LIMA, PERU --
Sign-up for Minera IRL Provides Update on Ollachea Financing Negotiations investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978727001&sourceType=1 http://www.ccnmatthews.com/logos/20090331-minera200.jpg LIMA, PERU --
Sign-up for Minera IRL Reports Third Quarter 2014 Results investment picks
2014/10/30
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- The U.K.'s FTSE 100 dropped for the first time in three days on Thursday, with miners leading the charge south as metal prices slumped.
Sign-up for Miners bruise FTSE 100 as metals prices slide investment picks
2014/12/16
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks fell Tuesday, with the benchmark FTSE 100 feeling the weight of losses among miners after poor data from China, but most bank stocks edged up after most major U.K. banks passed the Bank of England's stress tests.
Sign-up for Miners drag FTSE 100 lower after gloomy China data investment picks
WALTHAM, Mass., Nov.
Sign-up for Minerva Neurosciences Appoints Dr. Remy Luthringer as CEO investment picks
Results provide further support for research involving use of neuregulin-1 compounds in treatment of Parkinson's and other neurodegenerative disorders WALTHAM, Mass., Jan.
Sign-up for Minerva Neurosciences Reports Positive Data Showing an Analog of Minerva's MIN-301 Compound Improves Symptoms of Parkinson's Disease in Primates investment picks
2015/1/21
Preliminary results provide additional support for progression of MIN-202 into next stage of clinical development.
Sign-up for Minerva Neurosciences Reports Positive Phase 1 Data With MIN-202, Selective Orexin-2 Antagonist for Treatment of Sleep Disorders Including Primary and Comorbid Insomnia investment picks
– Advanced Lead Compound MIN-101 in Once-daily Formulation with Topline Results Expected in 4Q14; Phase 2b Study Expected to be Submitted in 4Q14 and Enrollment Expected to Begin in 1H15 – WALTHAM, Mass., Nov.
Sign-up for Minerva Neurosciences Reports Third Quarter 2014 Financial Results investment picks
Minerva Neurosciences Inc. (NERV) shares rallied after the clinical-stage biotech reported study results that support its Parkinson's treatment.
Sign-up for Minerva Neurosciences shares rally on animal Parkinson's study investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: MiMedx Announces Receipt Of Civil Subpoena to Minerva Neurosciences shares rally on animal Parkinson's study
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent